The Longevity Multiplier: The Financial Impact of a 100-Year Life
If we live longer, the pension system dies. We analyze the 'Anti-Aging' industry and the total restructuring of work, wealth, and inheritance.
11 articles tagged Health.
If we live longer, the pension system dies. We analyze the 'Anti-Aging' industry and the total restructuring of work, wealth, and inheritance.
The first neural implants are entering clinical trials. We analyze the market for 'Cognitive Augmentation' and the divide between human and trans-human.
Drug development takes 10 years and $2 billion. We analyze how 'In-Silico' modeling is slashing R&D timelines and bankrupting traditional labs.
Designing life is easy; getting it approved is hard. We analyze the divergent regulatory paths of the US, EU, and China in synthetic biology.
Biological manufacturing is expensive. We analyze the 'Valley of Death' for bio-startups and the struggle for sustainable scale in the carbon-economy.
If humans live longer, the pension system dies. We analyze the rise of 'Longevity Derivatives' and the financial cost of radical life extension.
Moving the farm to the city reduces logistics cost but increases energy cost. We analyze the breaking point of vertical farming economics in 2026.
Engineered microbes are the new industrial cleaners. We analyze the financial potential of biological pollution-scrubbing and the 'Great Cleanup' of the 21st century.
In a hyper-connected world, true silence is the ultimate luxury asset. We analyze the rise of 'Acoustic Real Estate' and the economics of quietude.
Brain-computer interfaces are turning attention and focus into a quantifiable asset. We analyze the rise of 'Neural Alpha' and the ethics of cognitive enhancement.
DNA is the new software. We analyze the rising trend of bio-foundries and the legal battles over genetic code ownership in the 2030 bio-economy.